GW 784568X

Drug Profile

GW 784568X

Alternative Names: 784568; GSK 784568; GW784568X

Latest Information Update: 19 Apr 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Class Antiallergics
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Allergic rhinitis

Most Recent Events

  • 19 Apr 2011 Discontinued - Phase-I/II for Allergic rhinitis in Germany (Intranasal)
  • 21 Jan 2008 GlaxoSmithKline has completed a phase I/II trial in Allergic Rhinitis
  • 01 Aug 2006 Phase-I/II clinical trials in Allergic rhinitis in Germany (Intranasal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top